Profil Financier
Viktor Kharitonin occupe actuellement le rang #499 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $7.9 B (-$27 sur 24h).
Viktor Kharitonin created multinational pharmaceutical firm Pharmstandard with Russian billionaire Roman Abramovich and other partners in 2003 by combining five factories.
Kharitonin and partner Egor Kulkov bought out the other investors in 2008, a year after Pharmstandard went public in London. They took Pharmstandard private again, eight years later.
Kharitonin and Kulkov also hold stakes in other Russian pharmaceuticals companies: OTCPharm, Biocad and Generium, one of the producers of the COVID-19 vaccine Sputnik V.
In 2022 The two partners tried to buy Russian assets of Austrian-British packaging and paper group Mondi for 1.5 billion euro, but Russian authorities rejected the deal.
In 2023 Kharitonin and his partners bought Russian assets of German chemical producer Henkel for 600 million euros, leaving Henkel the option of buying back the business.
In October 2014 Kharitonin became co-owner of Nurbugring in Germany, one of the oldest race tracks in Europe.
The Novosibirsk State University graduate got his start selling consumer goods.